Vioxx Plaintiff Has Choice of $1.6 Million or New Trial

Mike Simon
Mike Simon
Contributor
Posted by Mike SimonJune 15, 2007 10:53 AM

Retired FBI agent Gerald Barnett, who claims that the painkiller Vioxx caused his 2002 heart attack, must choose between $1.6 million and a retrial of his claims, a federal judge ruled. Last September a jury awarded Barnett $1 million in punitive damages and $50 million in compensatory damages, but U.S. District Judge Eldon E. Fallon ordered a retrial on damages, ruling that $50 million in compensatory damages was "excessive under any conceivable standard of excessiveness."

Taking evidence into consideration, Fallon ruled that $600,000 is a reasonable amount for compensatory damages. Barnett's attorney, Mark Robinson, declared that he would advise his client to accept the reduced damages.

Drug maker Merck & Co. stopped selling Vioxx in 2004 in response to evidence linking the painkiller with an increased risk of heart attack and stroke. Merck did, however, file a motion for a new trial on all issues, but was denied when Fallon ruled that it was sufficient that a jury found Merck liable of negligence for concealing risks from Barnett's doctors.


0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard West Virginia

InjuryBoard West Virginia RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address